1. A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48. Issue 33 (August 2019) Authors: Liang, Rong-Yue; Xu, Jing-Hang; Si, Chong-Wen; Wang, Sa; Shang, Jia; Yu, Zu-Jiang; Mao, Qing; Xie, Qing; Zhao, Wei; Li, Jun; Gao, Zhi-Liang; Wu, Shan-Ming; Tang, Hong; Cheng, Jun; Chen, Xin-Yue; Zhang, Wen-Hong; Wang, Hao; Xu, Zhong-Nan; Wang, Ling; Dai, Jun Other Names: Lin. Wenyu section editor. Journal: Medicine Issue: Volume 98:Issue 33(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Global multi-stakeholder endorsement of the MAFLD definition. (May 2022) Authors: Méndez-Sánchez, Nahum; Bugianesi, Elisabetta; Gish, Robert G; Lammert, Frank; Tilg, Herbert; Nguyen, Mindie H; Sarin, Shiv K; Fabrellas, Núria; Zelber-Sagi, Shira; Fan, Jian-Gao; Shiha, Gamal; Targher, Giovanni; Zheng, Ming-Hua; Chan, Wah-Kheong; Vinker, Shlomo; Kawaguchi, Takumi; Castera, Lauren... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 5(2022) Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗